The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2017-01-01
-Paragraph 45
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=7&date=2017-03-01&anchor=para_45&doctype=Standard
-URIDate 2017-03-09

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2017-01-01
-Paragraph B13
-Subparagraph a
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2017-03-01&anchor=para_B13_a&doctype=Appendix&seq=2
-URIDate 2017-03-09

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2017-01-01
-Paragraph 54
-Subparagraph i
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2017-03-01&anchor=para_54_i&doctype=Standard
-URIDate 2017-03-09

Name:	ifrs-full_CashAndCashEquivalents
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

FINANCIAL RISK MANAGEMENT - Liquidity risk (Details) - USD ($)		12 Months Ended
	Nov. 17, 2017	Dec. 31, 2017	Nov. 13, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Liquidity Risk
Cash and cash equivalents		$ 17,507,157		$ 22,954,571	$ 55,026,171	$ 5,193,561
Cash held in escrow				$ 70,000,000
Gross proceeds from 2017 financing		$ 65,324,997
CardiAQ
Liquidity Risk
Cash held in escrow			$ 70,000,000
Remaining damages became due and payable			$ 42,000,000
Amount of financing proceeds used to settle the damages and interest awards	$ 42,000,000